drugset / Trial / NCT04124913

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles

NCT04124913

Phase 4 Unknown 140 enrolled Memorial Sisli Hospital, Istanbul
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this randomized controlled trial is to compare the efficacy of oral dydrogesterone vs. micronized vaginal progesterone for luteal phase support in frozen-thawed embryo transfer cycles.

Timeline

Start
2019-01-02
Primary completion
2019-10
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 10 mg Oral
Comparator Progesterone Other / unclassified 90 mg Other